FDA issued a Warning Letter to ID Biomedical Corp., a subsidary of GSK Biologicals on 6/12/2014 for a later inspection.
483 ID Biomedical, a subsidary of GSK Biologicals May 2009

483 ID Biomedical, a subsidary of GSK Biologicals May 2009

Jacqueline Diaz Albert FDA$119.00 - Available Now

FDA investigators audited the ID Biomedical, a subsidary of GSK Biologicals - St. Foy, Canada facility and issued inspectional observations (via FDA 483) on 28 May 2009.

Product details

  • Category: Biologics
  • Inspection end: 28 May 2009
  • Location: St. Foy, Canada
  • FEI: 3004835647
Add To Cart